MÜDERRİSOĞLU, A. Et Al. 2018. EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY. BASIC CLINICAL PHARMACOLOGY TOXICOLOGY , 6.

MÜDERRİSOĞLU, A., BABAOĞLU, E., KORKMAZ, E. T., ONGUN, M. C., KARABULUT, E., EMRİ, K. A. S., ... BABAOĞLU, M. Ö.(2018). EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY . BASIC CLINICAL PHARMACOLOGY TOXICOLOGY (pp.6).

MÜDERRİSOĞLU, AHMET Et Al. "EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY," BASIC CLINICAL PHARMACOLOGY TOXICOLOGY, 2018

MÜDERRİSOĞLU, AHMET Et Al. "EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY." BASIC CLINICAL PHARMACOLOGY TOXICOLOGY , pp.6, 2018

MÜDERRİSOĞLU, A. Et Al. (2018) . "EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY." BASIC CLINICAL PHARMACOLOGY TOXICOLOGY , p.6.

@conferencepaper{conferencepaper, author={AHMET MÜDERRİSOĞLU Et Al. }, title={EFFECTS OF A GENETIC POLYMORPHISM OF HUMAN CYP2B6 ON NICOTINE DEPENDENCE AND SMOKING CESSATION THERAPY}, congress name={BASIC CLINICAL PHARMACOLOGY TOXICOLOGY}, city={}, country={}, year={2018}, pages={6} }